KMTS · Kestra Medical Technologies, Ltd.
Kestra Medical Technologies Ltd (KMTS)
What's happening
- KMTS is down 1.36% today, trading at $25.39. — Live quote
- Volume today (356) is well below its 3-month average of 335,520. (Finnhub fundamentals)
- Reports earnings on 2026-09-14, 11 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.67 actual vs. $-0.61 estimated (-10.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2026-09-01 (14 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Quarterly history (3 periods)
| Measure | Jan '26 | Oct '25 | Jul '25 |
|---|---|---|---|
| Market cap | $1.38B | $1.41B | $852.3M |
| P/E | -12.08 | -14.03 | -9.73 |
| Price/Sales | 16.92 | 19.65 | 13.76 |
| EV/Revenue | 13.87 | 17.79 | 11.18 |
| EV/EBITDA | -10.50 | -13.84 | -8.78 |
| ROA | -30.13% | -40.73% | -32.89% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E and PEG aren't shown here — both need historical analyst-consensus estimates, which no free source provides; see the current-period figures above instead.
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-14. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Signals describe daily price patterns—not the company’s value and not a recommendation to buy or sell. Read several together; no single indicator predicts what happens next. “Overbought” and “oversold” are conditions, not promises of a reversal.
Indicators None active
Free IEX historical data only goes back to ~2021 — 5Y/Full show whatever's actually available, not a promise of that much history. Indicators are computed client-side from these same price bars; earnings markers ("E") come from Finnhub's free tier (~last 4 quarters + next upcoming) — older quarters aren't available. The move-highlight dots are a heuristic (|% change| vs rolling volatility) with a best-effort headline lookup, not a claim of causation.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 66.2% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +55.8%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -138.4%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-08-18; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on KMTS
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jan '26 | Oct '25 | Jul '25 | Jan '25 | Oct '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Revenue | $24.6M | $22.6M | $19.4M | $15.1M | $14.7M | $12.8M |
| Gross profit | $12.9M | $11.4M | $8.9M | $6.5M | $5.8M | $4.2M |
| Operating income | -$34.8M | -$31.8M | -$28.9M | -$20.6M | -$19.1M | -$18.4M |
| Net income | -$34.2M | -$32.8M | -$25.8M | -$21.5M | -$20.4M | -$19.9M |
| EPS (diluted) | $-0.61 | $-0.64 | $-0.50 | $-1.25 | $-1.19 | $-1.12 |
| EPS (basic) | $-0.61 | $-0.64 | $-0.50 | $-1.25 | $-1.19 | $-1.12 |
| Operating margin | -$142 | -$141 | -$149 | -$137 | -$130 | -$144 |
| Net margin | -$139 | -$145 | -$133 | -$143 | -$138 | -$156 |
Balance sheet
| Line item | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Jul '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $358.5M | $379.3M | $246.7M | $266.3M | $295.7M | — | — | — |
| Total liabilities | $98.8M | $91.4M | $82.6M | $82.1M | $90.3M | — | — | — |
| Total current assets | $222.4M | $314.1M | $195.4M | $220.7M | $255.3M | — | — | — |
| Total current liabilities | $50.4M | $42.9M | $35.8M | $32.3M | $38.0M | — | — | — |
| Cash & equivalents | $99.7M | $291.3M | $175.4M | $201.2M | $237.6M | $54.4M | $76.9M | $100.0M |
| Marketable securities (current) | $96.7M | — | — | — | — | — | — | — |
| Accounts receivable | $14.5M | $12.7M | $10.4M | $9.2M | $8.1M | — | — | — |
| Other current assets | $3.0M | $1.5M | $1.4M | $1.6M | $1.7M | — | — | — |
| Marketable securities (non-current) | $65.8M | — | — | — | — | — | — | — |
| Property, plant & equipment | $59.1M | $53.8M | $45.9M | $40.4M | $34.8M | — | — | — |
| Other non-current assets | $5.8M | $5.9M | $1.2M | $1.1M | $1.2M | — | — | — |
| Accounts payable | $27.3M | $24.0M | $20.2M | $18.6M | $24.0M | — | — | — |
| Accrued liabilities | $23.0M | $18.9M | $15.5M | $13.7M | $13.8M | — | — | — |
| Long-term debt | $42.6M | $42.3M | $41.9M | $41.5M | $41.1M | — | — | — |
| Other non-current liabilities | $306.0K | $140.0K | $140.0K | $140.0K | $140.0K | — | — | — |
| Common stock & paid-in capital | $58.4M | $58.3M | $51.4M | $51.3M | $51.3M | $100 | — | — |
| Retained earnings | -$651.9M | -$613.0M | -$578.9M | -$546.1M | -$520.2M | — | — | — |
| Accumulated other comprehensive income (loss) | -$218.0K | — | — | — | — | — | — | — |
Cash flow
| Line item | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Jul '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$18.7M | -$18.4M | -$18.3M | -$26.3M | -$24.1M | -$18.0M | -$18.1M | -$17.5M |
| Investing cash flow | -$172.7M | -$14.9M | -$7.4M | -$8.2M | -$7.4M | -$4.5M | -$4.4M | -$7.0M |
| Financing cash flow | -$185.0K | $149.2M | -$27.0K | -$1.9M | $214.7M | -$119.0K | -$575.0K | $116.3M |
| Free cash flow | -$28.4M | -$28.2M | -$25.6M | -$34.4M | -$31.4M | -$22.1M | -$22.5M | -$24.5M |
| Capital expenditures | $9.7M | $9.8M | $7.3M | $8.2M | $7.4M | $4.1M | $4.4M | $7.0M |
| Depreciation & amortization | $2.3M | $2.0M | $2.4M | $2.0M | $1.8M | $1.9M | $1.9M | $2.4M |
| Share-based compensation | $10.3M | $10.1M | $8.7M | $4.6M | $22.3M | $459.0K | $1.1M | $377.0K |
| Deferred income taxes | $166.0K | — | — | — | $64.0K | — | — | — |
| Change in accounts receivable | $2.9M | $2.7M | $1.7M | $1.8M | $963.0K | $3.3M | $1.6M | $2.9M |
| Change in accounts payable | $4.9M | $1.7M | $524.0K | -$2.9M | -$823.0K | $4.0M | -$2.6M | $2.3M |
| Purchases of investments | $163.0M | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
Income statement
| Line item | Apr '26 | Apr '25 | Apr '24 |
|---|---|---|---|
| Revenue | $95.1M | $59.8M | $27.8M |
| Gross profit | $48.9M | $24.2M | $362.0K |
| Operating income | -$134.7M | -$106.4M | -$85.1M |
| Net income | -$131.6M | -$113.8M | -$94.1M |
| EPS (diluted) | $-2.43 | $-5.13 | $-5.07 |
| EPS (basic) | $-2.43 | $-5.13 | $-5.07 |
| Operating margin | -$142 | -$178 | -$306 |
| Net margin | -$138 | -$190 | -$338 |
Balance sheet
| Line item | Apr '26 | Apr '25 | Apr '24 |
|---|---|---|---|
| Total assets | $358.5M | $295.7M | $45.9M |
| Total liabilities | $98.8M | $90.3M | $78.2M |
| Total current assets | $222.4M | $255.3M | $14.9M |
| Total current liabilities | $50.4M | $38.0M | $33.0M |
| Cash & equivalents | $99.7M | $237.6M | $8.2M |
| Marketable securities (current) | $96.7M | — | — |
| Accounts receivable | $14.5M | $8.1M | $2.0M |
| Other current assets | $3.0M | $1.7M | $419.0K |
| Marketable securities (non-current) | $65.8M | — | — |
| Property, plant & equipment | $59.1M | $34.8M | $26.1M |
| Other non-current assets | $5.8M | $1.2M | $607.0K |
| Accounts payable | $27.3M | $24.0M | $23.9M |
| Accrued liabilities | $23.0M | $13.8M | $9.1M |
| Long-term debt | $42.6M | $41.1M | $42.5M |
| Other non-current liabilities | $306.0K | $140.0K | $76.0K |
| Common stock & paid-in capital | $58.4M | $51.3M | $19.9M |
| Retained earnings | -$651.9M | -$520.2M | -$406.4M |
| Accumulated other comprehensive income (loss) | -$218.0K | — | — |
Cash flow
| Line item | Apr '26 | Apr '25 | Apr '24 |
|---|---|---|---|
| Operating cash flow | -$81.7M | -$77.6M | -$72.2M |
| Investing cash flow | -$203.3M | -$23.3M | -$12.2M |
| Financing cash flow | $147.1M | $330.3M | $77.7M |
| Free cash flow | -$116.6M | -$100.5M | -$84.5M |
| Capital expenditures | $34.9M | $22.9M | $12.2M |
| Depreciation & amortization | $8.7M | $8.0M | $11.6M |
| Share-based compensation | $33.6M | $24.3M | $1.5M |
| Deferred income taxes | $166.0K | $64.0K | $12.0K |
| Change in accounts receivable | $9.1M | $8.8M | $2.5M |
| Change in accounts payable | $4.3M | $2.8M | $7.3M |
| Purchases of investments | $163.0M | — | — |
| Debt issued | — | — | $45.0M |
| Debt repaid | — | — | $39.1M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding KMTS as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-05-15 to 2026-08-17
Recent transactions
- Insiders have net sold 268,164 shares over the last 182 days, across 0 purchases and 31 sales.
- Most recent: Webster Brian Daniel (See Remarks) — Open market sale of 15,000 shares on 2026-08-17.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Webster Brian Daniel | See Remarks | Open market sale | 2026-08-17 | 15,000 |
| Mahboob Vaseem | Chief Financial Officer | Open market sale | 2026-08-07 | 25,787 |
| Ford Alfred J Jr | Chief Commercial Officer | Open market sale | 2026-08-04 | 6,275 |
| Umberger Traci S | See Remarks | Open market sale | 2026-08-04 | 3,580 |
| Moran Timothy P. | Chief Business Officer | Open market sale | 2026-08-03 | 2,380 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-17 | Webster Brian Daniel | See Remarks | Open market sale | 15,000 | $27.48 |
| 2026-08-07 | Mahboob Vaseem | Chief Financial Officer | Open market sale | 25,787 | $25.87 |
| 2026-08-07 | Mahboob Vaseem | Chief Financial Officer | Open market sale | 500 | $26.33 |
| 2026-08-04 | Ford Alfred J Jr | Chief Commercial Officer | Open market sale | 6,275 | $24.09 |
| 2026-08-04 | Mahboob Vaseem | Chief Financial Officer | Open market sale | 3,080 | $24.06 |
| 2026-08-04 | Mahboob Vaseem | Chief Financial Officer | Open market sale | 3,915 | $25.17 |
| 2026-08-04 | Umberger Traci S | See Remarks | Open market sale | 3,580 | $24.04 |
| 2026-08-04 | Webster Brian Daniel | See Remarks | Open market sale | 48,625 | $24.47 |
| 2026-08-04 | Webster Brian Daniel | See Remarks | Open market sale | 2,833 | $25.16 |
| 2026-08-04 | Webster Brian Daniel | See Remarks | Open market sale | 442 | $25.98 |
| 2026-08-03 | Moran Timothy P. | Chief Business Officer | Open market sale | 2,380 | $23.76 |
| 2026-08-03 | Ford Alfred J Jr | Chief Commercial Officer | Open market sale | 13,015 | $23.90 |
| 2026-08-03 | Mahboob Vaseem | Chief Financial Officer | Open market sale | 5,391 | $23.80 |
| 2026-08-03 | Umberger Traci S | See Remarks | Open market sale | 7,590 | $23.86 |
| 2026-08-03 | Webster Brian Daniel | See Remarks | Open market sale | 13,017 | $23.92 |
| 2026-07-31 | Moran Timothy P. | Chief Business Officer | Open market sale | 8,759 | $22.61 |
| 2026-07-31 | Ford Alfred J Jr | Chief Commercial Officer | Open market sale | 8,681 | $22.61 |
| 2026-07-31 | Mahboob Vaseem | Chief Financial Officer | Open market sale | 8,817 | $22.61 |
| 2026-07-31 | Umberger Traci S | See Remarks | Open market sale | 8,752 | $22.60 |
| 2026-07-31 | Webster Brian Daniel | See Remarks | Open market sale | 8,948 | $22.60 |
| 2026-07-30 | Moran Timothy P. | Chief Business Officer | Open market sale | 4,117 | $22.77 |
| 2026-07-30 | Ford Alfred J Jr | Chief Commercial Officer | Open market sale | 5,936 | $22.76 |
| 2026-07-30 | Mahboob Vaseem | Chief Financial Officer | Open market sale | 3,980 | $22.75 |
| 2026-07-30 | Umberger Traci S | See Remarks | Open market sale | 5,887 | $22.74 |
| 2026-07-30 | Webster Brian Daniel | See Remarks | Open market sale | 7,857 | $22.72 |
| 2026-07-16 | Moran Timothy P. | Chief Business Officer | Grant / award | 39,113 | $0.00 |
| 2026-07-15 | Ford Alfred J Jr | Chief Commercial Officer | Grant / award | 58,832 | $0.00 |
| 2026-07-15 | Mahboob Vaseem | Chief Financial Officer | Grant / award | 44,118 | $0.00 |
| 2026-07-15 | Umberger Traci S | See Remarks | Grant / award | 58,832 | $0.00 |
| 2026-07-15 | Webster Brian Daniel | See Remarks | Grant / award | 176,470 | $0.00 |
| 2026-07-15 | Webster Brian Daniel | See Remarks | Open market sale | 11,216 | $22.01 |
| 2026-07-15 | Webster Brian Daniel | See Remarks | Open market sale | 784 | $22.63 |
| 2026-07-15 | Webster Brian Daniel | See Remarks | Open market sale | 3,000 | $24.00 |
| 2026-06-30 | Moran Timothy P. | Chief Business Officer | Grant / award | 227 | $21.55 |
| 2026-06-30 | Umberger Traci S | See Remarks | Grant / award | 942 | $21.55 |
| 2026-06-15 | Webster Brian Daniel | See Remarks | Open market sale | 15,000 | $20.81 |
| 2026-06-03 | Moran Timothy P. | Chief Business Officer | Grant / award | 22,704 | $0.00 |
| 2026-06-03 | Ford Alfred J Jr | Chief Commercial Officer | Grant / award | 25,227 | $0.00 |
| 2026-06-03 | Mahboob Vaseem | Chief Financial Officer | Grant / award | 25,227 | $0.00 |
| 2026-06-03 | Umberger Traci S | See Remarks | Grant / award | 25,227 | $0.00 |
| 2026-06-03 | Webster Brian Daniel | See Remarks | Grant / award | 75,681 | $0.00 |
| 2026-05-15 | Webster Brian Daniel | See Remarks | Open market sale | 8,155 | $20.53 |
| 2026-05-15 | Webster Brian Daniel | See Remarks | Open market sale | 6,845 | $21.46 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-09-03 11:53 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-18 | 4 | 2026-08-17 | View on SEC.gov → |
| 2026-08-11 | 4 | 2026-08-07 | View on SEC.gov → |
| 2026-08-06 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-08-06 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-08-06 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-08-06 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-08-03 | 4 | 2026-07-30 | View on SEC.gov → |
| 2026-08-03 | 4 | 2026-07-30 | View on SEC.gov → |
| 2026-08-03 | 4 | 2026-07-30 | View on SEC.gov → |
| 2026-08-03 | 4 | 2026-07-30 | View on SEC.gov → |
| 2026-08-03 | 4 | 2026-07-30 | View on SEC.gov → |
| 2026-07-17 | 4 | 2026-07-15 | View on SEC.gov → |
Recent news
Headlines about KMTS (Kestra Medical Technologies, Ltd.). Links open the publisher — we don’t host full articles.
-
Phreesia (PHR) Q2 Earnings and Revenues Lag Estimates
Yahoo Finance · 2026-09-02 -
BTIG Reiterates Buy on Kestra Medical Techs, Maintains $32 Price Target
Benzinga · 2026-09-02 -
Medtronic (MDT) Q1 Earnings and Revenues Top Estimates
Yahoo Finance · 2026-09-01 -
Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates
Yahoo Finance · 2026-08-26 -
Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience
Yahoo Finance · 2026-08-26 -
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 2026-08-25 -
Apple downgraded, HPE upgraded: Wall Street's top analyst calls
Yahoo Finance · 2026-08-10 -
Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?
Yahoo Finance · 2026-08-05
No headlines in this category right now — try “All”.